Posticy
Boost your SEO with Backlinks that are worth it
SR Ranko
Turn scattered startup information into focused action.
SR Booster
Submit your startup to 120+ top directories.

Merck & Co., Inc. - KalVista Pharmaceuticals

Merck & Co., Inc. acquires KalVista Pharmaceuticals

Announced: October 10, 2017

Type:           Acquisition
Status:         Complete

Amount:       $ 752,000,000

Acquisition News

Add News

Date Title
There are no news.

Merck & Co., Inc. Other Acquisitions

Add Acquisition

Date Acquired Amount
Sep 06, 2017
Rigontec GmbH
Undisclosed amount
Jul 11, 2016
StayWell Company
Undisclosed amount
Jun 09, 2016
Afferent Pharmaceuticals
$ 1,250,000,000
Jan 13, 2016
IOmet Pharma
Undisclosed amount
Jul 28, 2015
cCAM Biotherapeutics
$ 95,000,000
View more acquisitions »